Skip to content
Drug Regulatory Authority of Pakistan

Drug Regulatory Authority of Pakistan

Ministry of National Health Services, Regulations & Coordination

اردو |  English
  • facebook
  • twitter
  • envelope

Menu

  • About Us
    • DRAP at a Glance
    • Organization
    • Legislation
    • Boards and Committees
    • Quality Management System
    • Contact Us
  • Therapeutic Goods
    • Drugs
    • Medical Devices
    • Alternative Medicine
    • Controlled Substances
    • Emergency Use Authorizations
    • Clinical Trials Oversight
    • Licensing and Inspections
    • Quality Controls Labs
    • Import & Export
    • Advertisement Approvals
  • Safety Info
    • Product Recalls
    • Safety Communication
    • Safety Reporting
    • Report a Problem
  • News & Updates
    • Regulatory Updates
    • Press Releases
    • Careers
    • Tenders
    • Events
  • Publications
    • Guidelines
    • Newsletters
    • Regulatory Procedures
    • Regulatory Fees
    • Application Forms
    • Public Consultation
    • Minutes of the Meetings
  • E-Services
    • MIS Systems
    • Online Verification Services
  • Covid-19
    • News & Updates
    • COVID-19 Drugs Availability
Home > News & Updates > Regulatory Updates > Licensing and Inspections > S.R.O 1347(I)/2021 (Notification Regarding Amendments in Rule 20A and Schedule-H of the Drugs (Licensing, Registering and Advertising) Rules,1976 Pertaining to Contract Manufacturing.

S.R.O 1347(I)/2021 (Notification Regarding Amendments in Rule 20A and Schedule-H of the Drugs (Licensing, Registering and Advertising) Rules,1976 Pertaining to Contract Manufacturing.

Murtaza Awan Licensing and Inspections, SROs October 15, 2021December 29, 2021Licensing
PDF FileDownload
  • ← Date Wise FIFO List of Applications For Provisional Enlistment Of Products Applied By Herbal/Unani Firms (FIFO List 2020)
  • Tender Notice for Hiring of Security Services →
  • DRAP at a Glance
    • What We Do?
    • Vision & Mission
    • CEO’s Message
    • Executive Management
  • Organization
    • Organizational Structure
    • Divisions
    • Policy Board
    • Members of Authority
    • Information and Transparency
    • Strategic Plan
  • Legislation
    • Acts
    • Rules
    • Regulations
    • SROs
    • Notifications
  • Boards and Committees
    • Central Licensing Board
    • Registration Board
    • Medical Devices Board
    • Enlistment Evaluation Committee
    • Pharmacovigilance RAE Committee
  • Quality Management System
    • Quality Policy
    • Management Reviews
  • Contact Us
  • Drugs
  • Medical Devices
  • Alternative Medicines
  • Controlled Substances
  • Licensing and Inspections
  • Clinical Trials
  • Pharmacovigilance
  • Advertisements
  • General

Quick Navigation

Archives

Drug Regulatory Authority of Pakistan

  • Islamabad | Karachi | Lahore | Peshawar | Quetta
  • Phone: 0800-03727 (Mon to Fri 08:00AM to 04:00PM)
  • Website: www.dra.gov.pk
Developed by MIS Division. All rights reserved to Drug Regulatory Authority of Pakistan
  • Contact Us
  • Report a Problem